Characterisation of potential anti-inflammatory next-generation probiotics resistant to bisphenol A

What is it about?

The prevalence of chronic non-communicable diseases, including obesity, metabolic syndrome and inflammatory diseases are increasingly worldwide. Environmental factors such as exposure to pollutants, such as plasticizers compounds (i.e., Bisphenol A (BPA)) play a role in the development of these inflammation related diseases. More than ever, it is important the isolation of potential Next-generation probiotics strains from human gut microbiota, that are able to biodegrade this xenobiotic providing new opportunities to modulate these diseases. In this paper, we describe and characterize specific BPA-tolerant bacteria with beneficial and anti-inflammatory properties that could survive to the effects of BPA exposure and concomitantly decrease the symptoms of the colitis.

Featured Image